• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.13%

    Unilife Corporation (UNIS)

    -NasdaqGM
    2.38 0.00(0.00%) Jun 2, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Unilife Corporation
    250 Cross Farm Lane
    York, PA 17406
    United States - Map
    Phone: 717-384-3400
    Fax: 717-384-3401
    Website: http://www.unilife.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:209

    Business Summary 

    Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod; Unifill Select, which allows an end-user to select and attach a needle at the time of injection; Unifill Nexus that is equipped with an integrated luer adapter to provide connectivity with needleless luer access devices; and Unifill Allure, which combines universal luer connectivity with automatic, user-controlled needle retraction. It also provides ReadyToGo platform of wearable injectors designed for pre-filled, disposable devices that can be worn by a patient over periods during the subcutaneous injection of therapies; LISA smart reusable auto-injector; and RITA disposable auto-injector, an ergonomic single-use product. In addition, the company offers drug reconstitution delivery systems, including AutoMix Presto, an automatic reconstitution for single-step mixing and injection; EZMix Genesis, a ventless one-step reconstitution and automatic user-controlled retraction; EZMix Engage, a one step reconstitution to attach and retract a needle; and EZMix Prodigy, a single-barrel reconstitution system with a pre-fillable syringe. Further, it provides ocular delivery systems comprising Ocu-ject for the delivery of microliter sized doses to the eye; Ocu-mix, a dual-chamber syringe platform to reconstitute or mix, and deliver various therapies into the eye with a single injection; and Depot-ject, which places a drug depot into the eye. Additionally, the company offers Micro-ject to optimize the delivery of therapies with microliter doses that are unsuited to conventional device technologies. It serves pharmaceutical and biotechnology companies. The company was founded in 2002 and is headquartered in York, Pennsylvania.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Unilife Corporation

    Corporate Governance 
    Unilife Corporation’s ISS Governance QuickScore as of May 1, 2015 is 7. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 5; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Alan D. Shortall , 61
    Chairman, Chief Exec. Officer, Member of Strategic Partnerships Committee and Chief Exec. Officer of UMSL
    702.00K1.84M
    Mr. Mark V. Iampietro BSc, 62
    Chief Compliance Officer and VP of Corp. Quality & Regulatory Affairs
    314.00K0.00
    Dr. Ramin Mojdeh Ph.D., 53
    Pres and Chief Operating Officer
    733.00K0.00
    Mr. John C. Ryan J.D., 45
    Sr. VP, Gen. Counsel and Sec.
    52.00K0.00
    Mr. Dennis P. Pyers BSc, CPA, 54
    Sr. VP and Controller
    314.00K0.00
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders